º£½ÇÉçÇø

Skip to main content Skip to navigation

Dr Harriet Walter

Supervisor Details

Research Interests

Chemoimmunotherapy has transformed outcomes for patients with high grade non-Hodgkin lymphoma (NHL); however, 20-30% of patients either fail to respond to or relapse early following CD20 targeted treatment requiring further treatment lines and often resulting in poorer clinical outcomes. Each year approximately 5000 people per year will be diagnosed in the UK with high grade NHL. My research interests are focused on understanding the mechanisms underlying inherent resistance to CD20 therapies and other small molecule inhibitors using advanced laboratory techniques.

Research Groups

I am the the clinical lead for the CRUK/NIHR Leicester ECMC and Director of the Hope Cancer Trials Centre. I am part of the NIHR Leicester Biomedical Research Centre Personalised Cancer Prevention and Treatment Theme and have collaborations with the Lifestyle and Respiratory and Infection Themes. I have ongoing collaborations with the School of Chemistry and Institute for Structural and Chemical Biology.


MIBTP Project Details

Primary supervisor for:

Co-supervisor on a project / projects with

Let us know you agree to cookies